500 related articles for article (PubMed ID: 32426090)
1. COVID-19, asthma, and biological therapies: What we need to know.
Morais-Almeida M; Aguiar R; Martin B; Ansotegui IJ; Ebisawa M; Arruda LK; Caminati M; Canonica GW; Carr T; Chupp G; Corren J; Dávila I; Park HS; Hanania NA; Rosenwasser L; Sánchez-Borges M; Virchow JC; Yáñez A; Bernstein JA; Caraballo L; Chang YS; Chikhladze M; Fiocchi A; González-Diaz SN; Tanno LK; Levin M; Ortega-Martell JA; Passalacqua G; Peden DB; Rouadi PW; Sublett JL; Wong GWK; Bleecker ER
World Allergy Organ J; 2020 May; 13(5):100126. PubMed ID: 32426090
[TBL] [Abstract][Full Text] [Related]
2. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
Katsaounou P; Buhl R; Brusselle G; Pfister P; Martínez R; Wahn U; Bousquet J
Respir Med; 2019 Apr; 150():51-62. PubMed ID: 30961951
[TBL] [Abstract][Full Text] [Related]
3. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).
Pfaar O; Bachert C; Bufe A; Buhl R; Ebner C; Eng P; Friedrichs F; Fuchs T; Hamelmann E; Hartwig-Bade D; Hering T; Huttegger I; Jung K; Klimek L; Kopp MV; Merk H; Rabe U; Saloga J; Schmid-Grendelmeier P; Schuster A; Schwerk N; Sitter H; Umpfenbach U; Wedi B; Wöhrl S; Worm M; Kleine-Tebbe J; Kaul S; Schwalfenberg A
Allergo J Int; 2014; 23(8):282-319. PubMed ID: 26120539
[TBL] [Abstract][Full Text] [Related]
4. Omalizumab for asthma in adults and children.
Normansell R; Walker S; Milan SJ; Walters EH; Nair P
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003559. PubMed ID: 24414989
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 and bronchial asthma: current perspectives.
Hojo M; Terada-Hirashima J; Sugiyama H
Glob Health Med; 2021 Apr; 3(2):67-72. PubMed ID: 33937568
[TBL] [Abstract][Full Text] [Related]
6. Real-Life Benefit of Omalizumab in Improving Control of Bronchial Asthma During COVID-19 Pandemic.
Leru PM; Anton VF
Cureus; 2021 Aug; 13(8):e17268. PubMed ID: 34422507
[TBL] [Abstract][Full Text] [Related]
7. SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics.
Papaioannou AI; Fouka E; Tzanakis N; Antoniou K; Samitas K; Zervas E; Kostikas K; Bartziokas K; Porpodis K; Papakosta D; Tzouvelekis A; Gerogianni I; Kotsiou O; Makris M; Rovina N; Vlachou G; Markatos M; Vittorakis S; Katsoulis K; Papanikolaou I; Afthinos A; Katsaounou P; Steiropoulos P; Latsios D; Dimakou K; Koukidou S; Hillas G; Tryfon S; Kallieri M; Georgopoulou A; Avarlis P; Bakakos P; Markopoulou K; Gaki E; Paspala A; Kyriakaki Z; Gourgoulianis KI; Papiris S; Loukides S
J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2588-2595. PubMed ID: 35752436
[TBL] [Abstract][Full Text] [Related]
8. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
[TBL] [Abstract][Full Text] [Related]
9. Does airborne pollen influence COVID-19 outbreak?
Ravindra K; Goyal A; Mor S
Sustain Cities Soc; 2021 Jul; 70():102887. PubMed ID: 33816082
[TBL] [Abstract][Full Text] [Related]
10. Asthma and severe acute respiratory syndrome coronavirus 2019: current evidence and knowledge gaps.
Assaf SM; Tarasevych SP; Diamant Z; Hanania NA
Curr Opin Pulm Med; 2021 Jan; 27(1):45-53. PubMed ID: 33065601
[TBL] [Abstract][Full Text] [Related]
11. Understanding and Managing Severe Asthma in the Context of COVID-19.
Kong-Cardoso B; Ribeiro A; Aguiar R; Pité H; Morais-Almeida M
Immunotargets Ther; 2021; 10():419-430. PubMed ID: 34926333
[TBL] [Abstract][Full Text] [Related]
12. Asthma and COVID-19: an update.
Adir Y; Saliba W; Beurnier A; Humbert M
Eur Respir Rev; 2021 Dec; 30(162):. PubMed ID: 34911694
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Self-Administration of Omalizumab in an Adolescent With Severe Asthma During SARS-CoV-2 Infection.
Paladini E; Giovannini M; Barni S; Liccioli G; Sarti L; Novembre E; Mori F
Front Pediatr; 2021; 9():675281. PubMed ID: 34938694
[TBL] [Abstract][Full Text] [Related]
14. Coronavirus disease 2019 and severe asthma.
Benfante A; Pirrello G; Sala F; Seminara G; Scichilone N
Curr Opin Allergy Clin Immunol; 2023 Apr; 23(2):193-198. PubMed ID: 36752375
[TBL] [Abstract][Full Text] [Related]
15. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)
Klimek L; Pfaar O; Worm M; Eiwegger T; Hagemann J; Ollert M; Untersmayr E; Hoffmann-Sommergruber K; Vultaggio A; Agache I; Bavbek S; Bossios A; Casper I; Chan S; Chatzipetrou A; Vogelberg C; Firinu D; Kauppi P; Kolios A; Kothari A; Matucci A; Palomares O; Szépfalusi Z; Pohl W; Hötzenecker W; Rosenkranz AR; Bergmann KC; Bieber T; Buhl R; Buters J; Darsow U; Keil T; Kleine-Tebbe J; Lau S; Maurer M; Merk H; Mösges R; Saloga J; Staubach P; Jappe U; Rabe KF; Rabe U; Vogelmeier C; Biedermann T; Jung K; Schlenter W; Ring J; Chaker A; Wehrmann W; Becker S; Freudelsperger L; Mülleneisen N; Nemat K; Czech W; Wrede H; Brehler R; Fuchs T; Tomazic PV; Aberer W; Fink-Wagner AH; Horak F; Wöhrl S; Niederberger-Leppin V; Pali-Schöll I; Pohl W; Roller-Wirnsberger R; Spranger O; Valenta R; Akdis M; Matricardi PM; Spertini F; Khaltaev N; Michel JP; Nicod L; Schmid-Grendelmeier P; Idzko M; Hamelmann E; Jakob T; Werfel T; Wagenmann M; Taube C; Jensen-Jarolim E; Korn S; Hentges F; Schwarze J; O Mahony L; Knol EF; Del Giacco S; Chivato Pérez T; Bousquet J; Bedbrook A; Zuberbier T; Akdis C; Jutel M
Allergol Select; 2020; 4():53-68. PubMed ID: 32915172
[TBL] [Abstract][Full Text] [Related]
16. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
17. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities.
Ky B; Mann DL
JACC CardioOncol; 2020 Jun; 2(2):254-269. PubMed ID: 32313885
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities.
Ky B; Mann DL
JACC Basic Transl Sci; 2020 May; 5(5):501-517. PubMed ID: 32309679
[TBL] [Abstract][Full Text] [Related]
20. Spotlight on omalizumab in allergic asthma.
Bang LM; Plosker GL
BioDrugs; 2004; 18(6):415-8. PubMed ID: 15571425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
